Clinical Trials Logo

Heart Failure NYHA Class II clinical trials

View clinical trials related to Heart Failure NYHA Class II.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06233695 Completed - Heart Failure Clinical Trials

Gender-based Differences in the Outcome of Treatment With Aldosterone Antagonists in Patients With Heart Failure

GBDAL-HF
Start date: October 15, 2022
Phase:
Study type: Observational

Heart failure (HF) is a major healthcare problem. In patients with Heart Failure with Reduced Ejection Fraction (HFrEF), aldosterone antagonists reduce mortality and hospitalization rate. Gender-related differences have been described in the regulation of renin angiotensin aldosterone system (RAAS), which is at the core of the pathophysiology of HF. Regarding gender-related differences in the use of MRAs, less is known about the effects of androgens on RAAS. In this single-center prospective cohort, a total of 100 adult (≥ 18 years) ambulatory patients of both sexes with the diagnosis of HF with HFrEF (LVEF≤ 40%) and NYHA class II-IV under optimized medical therapy started an aldosterone antagonist are enrolled and followed-up for 6 months. Patients are categorized according to their apparent sexual gender into two groups: the male group and the female group.

NCT ID: NCT04741191 Completed - Clinical trials for Heart Failure NYHA Class II

Cycle Ergometer Training and Heart Failure on Heart Rate Recovery and Mind Fullness

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

To evaluate the effects of cycle ergometer training on heart rate recovery in Newyork Heart Association (NYHA) class I and II heart patients. To evaluate the effects of cycle ergometer training on mind fullness in NYHA class I and II heart patients. Previous studies were designed to target only cardiac functions and no psychological aspect was studied so this study cover this aspect as well so from the outcomes of this study we can determine both psychological satisfaction and cardiac function as well.

NCT ID: NCT04218435 Completed - Clinical trials for Heart Failure NYHA Class IV

Impact of Sacubitril/Valsartan on Quality of Life and Mortality of CKD vs Non-CKD in Heart Failure Patients

Start date: January 1, 2019
Phase:
Study type: Observational

The two primary goals of it's management are preventing further disease progression(mortality,hospitalizations and deterioration of left ventricular function)and alleviating patient suffering

NCT ID: NCT03895073 Completed - Heart Failure Clinical Trials

HEart fAiluRe evaluaTion Questionnaire

HEART
Start date: September 1, 2018
Phase:
Study type: Observational

The "four-point" questionnaire by Severo and his associates was weighted in 2011 in the Portuguese population and aims to characterize the severity of the symptoms of heart failure by providing a way to minimize the reliability of the NYHA classification. The questionnaire consists of four closed questions, three possible single-choice answers, coded 0, 1 or 2, and has been translated into Greek in accordance with the internationally-based methodology, with forward-backward translation.

NCT ID: NCT03424265 Completed - Clinical trials for Heart Failure NYHA Class II

Nutritional Therapy Interventions in Heart Failure

Start date: February 15, 2018
Phase: N/A
Study type: Interventional

The investigators will examine the effects of 12-weeks of nutritional interventions in older participants who have a symptom of mild to moderate heart failure.

NCT ID: NCT03388918 Completed - Clinical trials for Acute Decompensated Heart Failure

Future Patient - Telerehabilitation of Heart Failure Patients

Start date: December 21, 2016
Phase: N/A
Study type: Interventional

The idea behind the Future Patient research project is to develop a telerehabilitation program and tools for patients with heart failure. The hypothesis for this study is that participation in a telerehabilitation program for patients with heart failure will increase the patients' quality of life and multi-parametric (subjective and objective) individualized monitoring in a telerehabilitation program for patients with heart failure will increase detection of worsening of symptoms and avoid future hospitalization of the HF-patients.

NCT ID: NCT03387813 Completed - Heart Failure Clinical Trials

Hemodynamic-GUIDEd Management of Heart Failure

GUIDE-HF
Start date: March 15, 2018
Phase: N/A
Study type: Interventional

The GUIDE-HF IDE clinical trial is intended to demonstrate the effectiveness of the CardioMEMS™ HF System in an expanded patient population including heart failure (HF) patients outside of the present indication, but at risk for future HF events or mortality.

NCT ID: NCT03095196 Completed - Heart Failure Clinical Trials

Multipolar CRT-d and Diabetes

Start date: September 1, 2012
Phase: N/A
Study type: Observational

Background: Type 2 Diabetes Mellitus (T2DM) is a multi factorial disease, affecting clinical outcomes in failing heart (HF) patients treated by Cardiac Resynchronization Therapy with a defibrillator (CRT-d). Methods: One hundred and ninety five T2DM patients will receive a CRT-d treatment. Randomly the study population will receive a CRT-d via multipolar left ventricle (LV) lead pacing (n 99 as Multipolar group), v/s a CRT-d via bipolar LV pacing (n 96, as Bipolar group). These patients will be followed by clinical, and instrumental assessment, and telemetric device control at follow up. Study design will be to evaluate, in failing heart T2DM patients, cardiac deaths, all cause deaths, arrhythmic events, CRT-d responders rate, hospitalizations for HF worsening, phrenic nerve stimulation (PNS), and LV catheter dislodgment events (and re-intervention for LV catheter re-positioning), comparing multipolar CRT-d v/s bipolar CRT-d group of patients at follow up.

NCT ID: NCT03035565 Completed - Clinical trials for Heart Failure NYHA Class III

Cognitive Intervention to Improve Memory in Heart Failure Patients

Memoir-HF
Start date: February 22, 2017
Phase: N/A
Study type: Interventional

Cognitive Intervention to Improve Memory in Heart Failure patients

NCT ID: NCT01560871 Completed - Clinical trials for Heart Failure NYHA Class III

Effects of a Walking Program and Inspiratory Muscle Training in Individuals With Chronic Heart Failure

Start date: March 2012
Phase: N/A
Study type: Interventional

Individuals with chronic heart failure need a "safe and effective" exercise program that could enhance their quality of life. In this study, we examined whether an experimental exercise program of autonomous walking and high-intensity Inspiratory Muscle Training (IMT) could result in better effects on respiratory muscle strength (PImax), cardiovascular endurance, quality of life, and physical activity, when compared to autonomous walking and "sham" IMT program, in adults with chronic heart failure.